MrMed

MrMed is a drug discovery company in Chennai, India. It has 1 recorded funding round, most recently a Seed in August 2023.

Buy Super Specialty Cancer Medicines Online with MrMed Pharmacy

Employees
51–200
Business Model
B2C
Website
mrmed.in
Last Round
SeedAug 2023
Rounds
1

Indexed holds 1 funding round for this company. The full record is or through the API.

About

MrMed operates an online pharmacy for super specialty medicines in India, helping patients procure medicines and adhere to patient assistance programs. Its services extend beyond medicine sales to support patients in obtaining treatments. The business combines its pharmacy offering with patient-focused services intended to improve access to specialty medicines.

Summary

It lists 51–200 employees. Its most recent funding was a Seed round in Aug 2023.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundAug 2023

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
Hims and HersIPO

Telehealth platform providing personalized health and wellness treatments for men and women, cove...

San Francisco, United States501–1000Digital Health, E-Commerce
ConvertibleTotal funding$2.6BJan 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MrMed on Indexed.vc
<a href="https://indexed.vc/companies/mrmed"><img src="https://indexed.vc/api/badge/company/mrmed" alt="MrMed on Indexed.vc" width="260" height="76" /></a>